Compare RECT & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RECT | AIDX |
|---|---|---|
| Founded | 1997 | N/A |
| Country | Singapore | United States |
| Employees | 111 | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 19.5M |
| IPO Year | N/A | N/A |
| Metric | RECT | AIDX |
|---|---|---|
| Price | $1.14 | $1.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.8K | ★ 126.0K |
| Earning Date | 07-24-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $1.51 |
| 52 Week High | $4.98 | $14.09 |
| Indicator | RECT | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 41.03 | 18.01 |
| Support Level | $1.04 | $1.51 |
| Resistance Level | $1.30 | $2.08 |
| Average True Range (ATR) | 0.10 | 0.21 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 50.07 | 67.75 |
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.